Key terms
About EXAI
Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest EXAI news
Mar 22
3:40am ET
Analysts’ Top Healthcare Picks: Healthequity (HQY), Exscientia Plc (EXAI)
Mar 21
9:22am ET
Exscientia files $300M mixed securities shelf
Mar 21
8:57am ET
Exscientia Plc Reports Progressive Drug Pipeline
Mar 21
7:04am ET
Exscientia reports Q4 EPS (42c), consensus (35c)
Mar 01
1:20pm ET
SHAREHOLDER ALERT: Potential Recovery for Exscientia plc (EXAI) Investors
Jan 05
7:30am ET
Exscientia downgraded at BofA on limited near-term inflection opportunities
Jan 05
6:06am ET
Exscientia downgraded to Neutral from Buy at BofA
No recent press releases are available for EXAI
EXAI Financials
Key terms
Ad Feedback
EXAI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
EXAI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
